Sunday, September 20, 2026

Niu Technologies And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

December 13, 2020

Niu Technologies And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Federal Agricultural Mortgage Corporation

13.3% sales growth and 12.67% return on equity

Federal Agricultural Mortgage Corporation provides a secondary market for various loans made to borrowers in the United States.

Federal Agricultural Mortgage Corporation sales growth this year is expected to be 10.7% and 4.8% for next year.

Year-on-year quarterly revenue growth grew by 28.9%, now sitting on 190.38M for the twelve trailing months.

Federal Agricultural Mortgage Corporation's sales growth for the next quarter is 13.3%. The company's growth estimates for the present quarter and the next is 0.9% and 23.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.67%.

Federal Agricultural Mortgage Corporation's Stock Top and Bottom Yearly Value

Federal Agricultural Mortgage Corporation's stock is valued at $75.35 at 04:57 EST, way below its 52-week high of $87.00 and way higher than its 52-week low of $40.05.

Federal Agricultural Mortgage Corporation's Moving Average

Federal Agricultural Mortgage Corporation's value is way higher than its 50-day moving average of $68.24 and way above its 200-day moving average of $66.17.

2. Everest Re Group, Ltd.

13.3% sales growth and 7.2% return on equity

Everest Re Group, Ltd., through its subsidiaries, provides reinsurance and insurance products in the United States, Bermuda, and internationally.

Everest Re Group, Ltd. sales growth this year is expected to be 16.2% and 11.5% for next year.

Year-on-year quarterly revenue growth grew by 23.1%, now sitting on 8.96B for the twelve trailing months.

Everest Re Group, Ltd.'s sales growth for the next quarter is 13.3%. The company's growth estimates for the ongoing quarter and the next is 36.6% and 66.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.2%.

Everest Re Group, Ltd.'s Stock Top and Bottom Yearly Value

Everest Re Group, Ltd.'s stock is valued at $231.62 at 04:57 EST, way under its 52-week high of $294.31 and way above its 52-week low of $157.32.

Everest Re Group, Ltd.'s Moving Average

Everest Re Group, Ltd.'s value is higher than its 50-day moving average of $224.91 and higher than its 200-day moving average of $215.01.

3. Atmos Energy Corporation

13.5% sales growth and 9.59% return on equity

Atmos Energy Corporation, together with its subsidiaries, engages in the regulated natural gas distribution, and pipeline and storage businesses in the United States.

Atmos Energy Corporation sales growth this year is anticipated to be 21.1% and 7.9% for next year.

Year-on-year quarterly revenue growth grew by 7%, now sitting on 2.82B for the twelve trailing months.

Atmos Energy Corporation's sales growth is a negative 0% for the current quarter and 13.5% for the next. The company's growth estimates for the present quarter and the next is 6.1% and 4.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.59%.

Atmos Energy Corporation's Stock Top and Bottom Yearly Value

Atmos Energy Corporation's stock is valued at $97.75 at 04:57 EST, way under its 52-week high of $121.08 and way above its 52-week low of $77.92.

Atmos Energy Corporation's Moving Average

Atmos Energy Corporation's value is above its 50-day moving average of $97.05 and below its 200-day moving average of $98.95.

4. Niu Technologies

138.2% sales growth and 20.55% return on equity

Niu Technologies designs, manufactures, and sells smart electric-scooters in the People's Republic of China.

Niu Technologies sales growth this year is expected to be 22.9% and 75.5% for next year.

Year-on-year quarterly revenue growth grew by 36.7%, now sitting on N/A for the twelve trailing months.

Niu Technologies's sales growth for the next quarter is 138.2%. The company's growth estimates for the ongoing quarter and the next is a negative 38.5% and 250%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.55%.

Niu Technologies's Stock Top and Bottom Yearly Value

Niu Technologies's stock is valued at $29.45 at 04:57 EST, way under its 52-week high of $37.44 and way above its 52-week low of $6.08.

Niu Technologies's Moving Average

Niu Technologies's value is under its 50-day moving average of $30.33 and way higher than its 200-day moving average of $21.61.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com